Surgical site infection impact of pelvic exenteration procedure

Journal of Surgical Oncology

Volumn 112, Issue 5, 2015, Pages 533-537

  Moghadamyeghaneh, Zhobin ^a   Hwang, Grace S ^a   Hanna, Mark H ^a   Carmichael, Joseph C ^a   Mills, Steven ^a   Pigazzi, Alessio ^a   Stamos, Michael J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

intra abdominal infections; rectal cancer; wound infection

Indexed keywords

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CANCER SURGERY; DEEP VEIN THROMBOSIS; DISSEMINATED CANCER; FEMALE; HEART ARREST; HEART INFARCTION; HUMAN; INFECTIOUS COMPLICATION; KIDNEY FAILURE; LENGTH OF STAY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OUTCOME ASSESSMENT; PELVIS EXENTERATION; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM CANCER; RECTUM RESECTION; SEPTIC SHOCK; SURGICAL INFECTION; SURGICAL MORTALITY; TREATMENT RESPONSE; URINARY TRACT INFECTION; WOUND DEHISCENCE; ABDOMINAL SURGERY; ADVERSE EFFECTS; COMPARATIVE STUDY; FOLLOW UP; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RECTAL NEOPLASMS; SURGICAL WOUND INFECTION;

DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MORBIDITY; PELVIC EXENTERATION; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RECTAL NEOPLASMS; SURGICAL WOUND INFECTION;

EID: 84945481486     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.24023     Document Type: Article

References (21)

1. Arjona-Sánchez A, Medina-Fernández FJ, Muñoz-Casares FC, et al.,: Peritoneal metastases of colorectal origin treated by cytoreduction and HIPEC: An overview. World J Gastrointest Oncol 2014; 6: 407-412.
2. Citarda F, Tomaselli G, Capocaccia R, et al.,: Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut 2001; 48: 812-815.
3. Ferenschild FT, Vermaas M, Verhoef C, et al.,: Total pelvic exenteration for primary and recurrent malignancies. World J Surg 2009; 33: 1502-1508.
4. López-Basave HN, Morales-Vásquez F, Herrera-Gómez A, et al.,: Pelvic exenteration for colorectal cancer: Oncologic outcome in 59 patients at a single institution. Cancer Manag Res 2012; 4: 351-356.
5. Pandey D, Zaidi S, Mahajan V, et al.,: Pelvic exenteration: A perspective from a regional cancer center in India. Indian J Cancer 2004; 41: 109-114.
6. Jimenez RE, Shoup M, Cohen AM, et al.,: Contemporary outcomes of total pelvic exenteration in the treatment of colorectal cancer. Dis Colon Rectum 2003; 46: 1619-1625.
7. Speicher PJ, Turley RS, Sloane JL, et al.,: Pelvic exenteration for the treatment of locally advanced colorectal and bladder malignancies in the modern era. J Gastrointest Surg 2014; 18: 782-788.
8. National Surgical Quality Improvement Program [home page on the Internet] Chicago, IL: American College of Surgeons; 2005. [cited 2012 Jan 17]. Available from: www.acsnsqip.org.
9. Gabay C, Kushner I,: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-454.
10. Banh L,: Serum proteins as markers of nutrition: What are we treating?. Pract Gastroenterol 2006; 30: 46-64.
11. Gibbs J, Cull W, Henderson W, et al.,: Preoperative serum albumin level as a predictor of operative mortality and morbidity: Results from the National VA Surgical Risk Study. Arch Surg 1999; 134: 36-42.
12. Lopez MJ, Kraybill WG, Downey RS, et al.,: Exenterative surgery for locally advanced rectosigmoid cancers. Is it worthwhile?. Surgery 1987; 102: 644-651.
13. Boey J, Wong J, Ong GB,: Pelvic exenteration for locally advanced colorectal carcinoma. Ann Surg 1982; 195: 513-518.
14. Kuhrt MP, Chokshi RJ, Arrese D, et al.,: Retrospective review of pelvic malignancies undergoing total pelvic exenteration. World J Surg Oncol 2012; 10: 110.
15. Yamada K, Ishizawa T, Niwa K, et al.,: Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer. Dis Colon Rectum 2002; 45: 1078-1084.
16. Nandipati K, Lin E, Husain F, et al.,: Factors predicting the increased risk for return to the operating room in bariatric patients: A NSQIP database study. Surg Endosc 2013; 27: 1172-1177.
17. Lee MJ, Cizik AM, Hamilton D, et al.,: Predicting surgical site infection after spine surgery: A validated model using a prospective surgical registry. Spine J 2014; 14: 2112-2117.
18. Bot J, Piessen G, Robb WB, et al.,: Advanced tumor stage is an independent risk factor of postoperative infectious complications after colorectal surgery: Arguments from a case-matched series. Dis Colon Rectum 2013; 56: 568-576.
19. Bernard AC, Davenport DL, Chang PK, et al.,: Intraoperative transfusion of 1U to 2U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients. J Am Coll Surg 2009; 208: 931-937. 937.e931-932; discussion 938-939.
20. Procter LD, Davenport DL, Bernard AC, et al.,: General surgical operative duration is associated with increased risk-adjusted infectious complication rates and length of hospital stay. J Am Coll Surg 2010; 210: 60-65. e61-62.
21. Tan TW, Kalish JA, Hamburg NM, et al.,: Shorter duration of femoral-popliteal bypass is associated with decreased surgical site infection and shorter hospital length of stay. J Am Coll Surg 2012; 215: 512-518.